ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,608.80
-0.01%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37275
0.41%
Bitcoin
63,087.92
-0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)

  7. Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ) News

APCVZ

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APCVZ
DateTimeSourceHeadlineSymbolCompany
03/07/20111:58PMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist & Deregister Contingent Value Rights for APP Pharmaceuti...NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/23/20115:04AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/23/20115:04AMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/23/201112:01AMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
01/26/20117:00AMBusiness WireAPP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
11/30/201012:01AMBusiness WireAPP Pharmaceuticals Announces Approval and Launch of Topotecan for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
11/05/20102:39PMBusiness WireAPP Pharmaceuticals to Launch Drug HotlineNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
11/02/20105:04AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
11/01/20107:16PMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
10/29/20105:53PMBusiness WireAPP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
08/02/20106:15PMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
08/02/20104:16PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
07/27/201012:14PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
07/06/201012:01AMBusiness WireAPP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/29/20101:44PMEdgar (US Regulatory)Annual Report of Employee Stock Plans (11-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/29/201012:01AMBusiness WireAPP Pharmaceuticals to Market Anastrozole Tablets in the U.S.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/22/201012:01AMBusiness WireAPP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/21/201012:01AMBusiness WireAPP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USPNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/11/201012:01AMBusiness WireAPP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
06/08/201012:01AMBusiness WireAPP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
05/10/20105:07AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
05/04/20105:04AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
05/03/20105:41PMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-QNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
04/01/201010:39AMBusiness WireFresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventisNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
03/31/20104:27PMEdgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
03/25/20108:15AMGlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on Fresenius Kabi Pharmaceuticals Holding, Inc.NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
03/23/201012:01AMBusiness WireAPP Pharmaceuticals Receives Approval for Indomethacin for InjectionNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/25/20102:43PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/24/20105:03AMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
02/23/20107:08PMBusiness WireFresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-KNASDAQ:APCVZFresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
 Showing the most relevant articles for your search:NASDAQ:APCVZ

Your Recent History

USOTC
MONI
Moon Equity (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
INKW
Greene Concepts (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
BLPG
Blue Line Protection (PK)
USOTC
AXXA
Exxe (PK)
USOTC
HNRC
Houston Natural Resources (PK)
USOTC
AHRO
Authentic (CE)
USOTC
MVNT
Movement Industries (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
XALL
Xalles (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
HMBL
HUMBL (PK)
USOTC
MGON
Megola (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved